Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share, Common Stock

OACC

NMQ

$10.2896

+$0.08

(0.78%)

Analyst Forecast

Overview Returns Financials Ratios News FAQs

Price Chart

Key Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$247.79M

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

39.16K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$9.95 L

$10.85 H

$10.2896

About Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share, Common Stock

Oaktree Acquisition Corp. III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California. more

Returns

Data is not properly formatted.

Time Frame	OACC		S&P500
1-Week Return	2.08%%	%	6.36%%
1-Month Return	1.03%%	%	-5.32%%
3-Month Return	3.08%%	%	-8.86%%
6-Month Return	2.9%%	%	-5.61%%

Financials

	Dec '24
Total Revenue	-	[{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue	-	[{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit	-	[{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin	-	[{"date":"2024-12-31","value":"-","profit":true}]

Operating Expenses	703.61	[{"date":"2024-12-31","value":100,"profit":true}]
Operating Income	(703.61)	[{"date":"2024-12-31","value":-70361,"profit":false}]
Total Non-Operating Income/Expense	-	[{"date":"2024-12-31","value":"-","profit":true}]
Pre-Tax Income	2.66K	[{"date":"2024-12-31","value":100,"profit":true}]
Income Taxes	-	[{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes	-	[{"date":"2024-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	[{"date":"2024-12-31","value":"-","profit":true}]
Income From Discontinued Operations	-	[{"date":"2024-12-31","value":"-","profit":true}]
Net Income	2.66K	[{"date":"2024-12-31","value":100,"profit":true}]

EPS (Diluted)	0.06	[{"date":"2024-12-31","value":100,"profit":true}]

	Dec '24
Total Revenue	-	[{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue	-	[{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit	-	[{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin	-	[{"date":"2024-12-31","value":"-","profit":true}]

Operating Expenses	-	[{"date":"2024-12-31","value":"-","profit":true}]
Operating Income	-	[{"date":"2024-12-31","value":"-","profit":true}]
Total Non-Operating Income/Expense	-	[{"date":"2024-12-31","value":"-","profit":true}]
Pre-Tax Income	-	[{"date":"2024-12-31","value":"-","profit":true}]
Income Taxes	-	[{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes	-	[{"date":"2024-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	[{"date":"2024-12-31","value":"-","profit":true}]
Income From Discontinued Operations	-	[{"date":"2024-12-31","value":"-","profit":true}]
Net Income	-	[{"date":"2024-12-31","value":"-","profit":true}]

EPS (Diluted)	-	[{"date":"2024-12-31","value":"-","profit":true}]

	Sep '24	Dec '24
Total Revenue	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Operating Expenses	48.09K	303.71K	[{"date":"2024-09-30","value":15.84,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income	(48.09K)	(303.71K)	[{"date":"2024-09-30","value":-4809500,"profit":false},{"date":"2024-12-31","value":-30371100,"profit":false}]
Total Non-Operating Income/Expense	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Pre-Tax Income	(48.09K)	1.38M	[{"date":"2024-09-30","value":-3.49,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income Taxes	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Income From Continuous Operations	(48.09K)	1.38M	[{"date":"2024-09-30","value":-3.49,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income From Discontinued Operations	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	(48.09K)	1.38M	[{"date":"2024-09-30","value":-3.49,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

EPS (Diluted)	-	0.06	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]

	Sep '24	Dec '24
Total Revenue	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Operating Expenses	-	531.48%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income	-	531.48%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Pre-Tax Income	-	(2968.91%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false}]
Income Taxes	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	(2968.91%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false}]
Income From Discontinued Operations	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	-	(2968.91%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false}]

EPS (Diluted)	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

	Dec '24
Total Assets
Current Assets	1.56M	[{"date":"2024-12-31","value":100,"profit":true}]
Non-current Assets	193.69M	[{"date":"2024-12-31","value":100,"profit":true}]
Total Assets	195.25M	[{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	727.32K	[{"date":"2024-12-31","value":100,"profit":true}]
Non-current Liabilities	7.02M	[{"date":"2024-12-31","value":100,"profit":true}]
Total Liabilities	7.75M	[{"date":"2024-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	193.58M	[{"date":"2024-12-31","value":100,"profit":true}]
Retained Earnings	(6.08M)	[{"date":"2024-12-31","value":-607500900,"profit":false}]
Other Stockholders' Equity	-	[{"date":"2024-12-31","value":"-","profit":true}]
Total Shareholders' equity	187.50M	[{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	195.25M	[{"date":"2024-12-31","value":100,"profit":true}]

	Dec '24
Total Assets
Current Assets	-	[{"date":"2024-12-31","value":"-","profit":true}]
Non-current Assets	-	[{"date":"2024-12-31","value":"-","profit":true}]
Total Assets	-	[{"date":"2024-12-31","value":"-","profit":true}]

Total Liabilities
Current Liabilities	-	[{"date":"2024-12-31","value":"-","profit":true}]
Non-current Liabilities	-	[{"date":"2024-12-31","value":"-","profit":true}]
Total Liabilities	-	[{"date":"2024-12-31","value":"-","profit":true}]

Total Shareholders' equity
Common Stock	-	[{"date":"2024-12-31","value":"-","profit":true}]
Retained Earnings	-	[{"date":"2024-12-31","value":"-","profit":true}]
Other Stockholders' Equity	-	[{"date":"2024-12-31","value":"-","profit":true}]
Total Shareholders' equity	-	[{"date":"2024-12-31","value":"-","profit":true}]

Total Liabilities & Shareholders Equity	-	[{"date":"2024-12-31","value":"-","profit":true}]

	Sep '24
Total Assets
Current Assets	-	[{"date":"2024-09-30","value":"-","profit":true}]
Non-current Assets	638.99K	[{"date":"2024-09-30","value":100,"profit":true}]
Total Assets	638.99K	[{"date":"2024-09-30","value":100,"profit":true}]

Total Liabilities
Current Liabilities	662.09K	[{"date":"2024-09-30","value":100,"profit":true}]
Non-current Liabilities	-	[{"date":"2024-09-30","value":"-","profit":true}]
Total Liabilities	662.09K	[{"date":"2024-09-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	503.00	[{"date":"2024-09-30","value":100,"profit":true}]
Retained Earnings	(48.09K)	[{"date":"2024-09-30","value":-4809500,"profit":false}]
Other Stockholders' Equity	24.50K	[{"date":"2024-09-30","value":100,"profit":true}]
Total Shareholders' equity	(23.09K)	[{"date":"2024-09-30","value":-2309500,"profit":false}]

Total Liabilities & Shareholders Equity	638.99K	[{"date":"2024-09-30","value":100,"profit":true}]

	Sep '24
Total Assets
Current Assets	-	[{"date":"2024-09-30","value":"-","profit":true}]
Non-current Assets	-	[{"date":"2024-09-30","value":"-","profit":true}]
Total Assets	-	[{"date":"2024-09-30","value":"-","profit":true}]

Total Liabilities
Current Liabilities	-	[{"date":"2024-09-30","value":"-","profit":true}]
Non-current Liabilities	-	[{"date":"2024-09-30","value":"-","profit":true}]
Total Liabilities	-	[{"date":"2024-09-30","value":"-","profit":true}]

Total Shareholders' equity
Common Stock	-	[{"date":"2024-09-30","value":"-","profit":true}]
Retained Earnings	-	[{"date":"2024-09-30","value":"-","profit":true}]
Other Stockholders' Equity	-	[{"date":"2024-09-30","value":"-","profit":true}]
Total Shareholders' equity	-	[{"date":"2024-09-30","value":"-","profit":true}]

Total Liabilities & Shareholders Equity	-	[{"date":"2024-09-30","value":"-","profit":true}]

	Dec '24
Operating Activities
Net Operating Cash Flow	(179.37)	[{"date":"2024-12-31","value":-17937,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	[{"date":"2024-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	386.87K	[{"date":"2024-12-31","value":100,"profit":true}]

Net Change in Cash	-	[{"date":"2024-12-31","value":"-","profit":true}]

Free Cash Flow
Free Cash Flow	(179.37)	[{"date":"2024-12-31","value":-17937,"profit":false}]

	Dec '24
Operating Activities
Net Operating Cash Flow	-	[{"date":"2024-12-31","value":"-","profit":true}]

Investing Activities
Net Investing Cash Flow	-	[{"date":"2024-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	[{"date":"2024-12-31","value":"-","profit":true}]

Net Change in Cash	-	[{"date":"2024-12-31","value":"-","profit":true}]

Free Cash Flow
Free Cash Flow	-	[{"date":"2024-12-31","value":"-","profit":true}]

	Sep '24	Dec '24
Operating Activities
Net Operating Cash Flow	-	(89.69K)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Net Change in Cash	-	1.36M	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	-	(89.69K)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false}]

	Sep '24	Dec '24
Operating Activities
Net Operating Cash Flow	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Investing Activities
Net Investing Cash Flow	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Net Change in Cash	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Free Cash Flow
Free Cash Flow	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Ratios

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	OACC
ROA (LTM)	0.00%
ROE (LTM)	0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	OACC
Debt Ratio Lower is generally better. Negative is bad.	1.04
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	-0.04

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	OACC
Trailing PE	NM
Forward PE	NM
P/S (TTM)	0.00
P/B	0.00
Price/FCF	NM
EV/R	0.00
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share share price today?

Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) share price today is $10.2896

Can Indians buy Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share shares?

Yes, Indians can buy shares of Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) on Vested. To buy Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in OACC stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share be purchased?

Yes, you can purchase fractional shares of Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) via the Vested app. You can start investing in Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) with a minimum investment of $1.

How to invest in Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share shares from India?

You can invest in shares of Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) via Vested in three simple steps:

Click on Sign Up or Invest in OACC stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share shares

What is Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share 52-week high and low stock price?

The 52-week high price of Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) is $10.85. The 52-week low price of Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) is $9.95.

What is Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) is 0.00

What is the Market Cap of Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share?

The market capitalization of Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) is $247.79M

What is Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share’s stock symbol?

The stock symbol (or ticker) of Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share is OACC